A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Recruiting · NCT07533942 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer | Recruiting | Phase 2 | 2026-07-30 | NCT07533942 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chimerix, Inc. | 2 |
| Jazz Pharmaceuticals | 60 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Louisiana State University | New Orleans | United States | 7 |
| Mass General | Boston | United States | 3 |
| NYU- Langone Health | New York | United States | 1 |
| Sutter Health | San Francisco | United States | 5 |
| University of Utah - Huntsman Cancer Institute | Salt Lake City | United States | 12 |